Literature DB >> 16939419

Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).

Michael A Cater1, Sharon La Fontaine, Julian F B Mercer.   

Abstract

The Wilson protein (ATP7B) is a copper-translocating P-type ATPase that mediates the excretion of excess copper from hepatocytes into bile. Excess copper causes the protein to traffic from the TGN (trans-Golgi network) to subapical vesicles. Using site-directed mutagenesis, mutations known or predicted to abrogate catalytic activity (copper translocation) were introduced into ATP7B and the effect of these mutations on the intracellular trafficking of the protein was investigated. Mutation of the critical aspartic acid residue in the phosphorylation domain (DKTGTIT) blocked copper-induced redistribution of ATP7B from the TGN, whereas mutation of the phosphatase domain [TGE (Thr-Gly-Glu)] trapped ATP7B at cytosolic vesicular compartments. Our findings demonstrate that ATP7B trafficking is regulated with its copper-translocation cycle, with cytosolic vesicular localization associated with the acyl-phosphate intermediate. In addition, mutation of the six N-terminal metal-binding sites and/or the trans-membrane CPC (Cys-Pro-Cys) motif did not suppress the constitutive vesicular localization of the ATP7B phosphatase domain mutant. These results suggested that copper co-ordination by these sites is not essential for trafficking. Importantly, copper-chelation studies with these mutants clearly demonstrated a requirement for copper in ATP7B trafficking, suggesting the presence of an additional copper-binding site(s) within the protein. The results presented in this report significantly advance our understanding of the regulatory mechanism that links copper-translocation activity with copper-induced intracellular trafficking of ATP7B, which is central to hepatic and hence systemic copper homoeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16939419      PMCID: PMC1698686          DOI: 10.1042/BJ20061055

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  The regulation of catalytic activity of the menkes copper-translocating P-type ATPase. Role of high affinity copper-binding sites.

Authors:  I Voskoboinik; J Mar; D Strausak; J Camakaris
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

2.  Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase.

Authors:  S M Vanderwerf; M J Cooper; I V Stetsenko; S Lutsenko
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

3.  Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.

Authors:  J R Forbes; D W Cox
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

4.  Copper-induced trafficking of the cU-ATPases: a key mechanism for copper homeostasis.

Authors:  Julian F B Mercer; Natalie Barnes; Julie Stevenson; Daniel Strausak; Roxana M Llanos
Journal:  Biometals       Date:  2003-03       Impact factor: 2.949

5.  Copper-regulated trafficking of the Menkes disease copper ATPase is associated with formation of a phosphorylated catalytic intermediate.

Authors:  Michael J Petris; Ilia Voskoboinik; Michael Cater; Kathryn Smith; Byung-Eun Kim; Roxana M Llanos; Daniel Strausak; James Camakaris; Julian F B Mercer
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

6.  Expression and localization of menkes and Wilson copper transporting ATPases in human placenta.

Authors:  B Hardman; U Manuelpillai; E M Wallace; S van de Waasenburg; M Cater; J F B Mercer; M L Ackland
Journal:  Placenta       Date:  2004-07       Impact factor: 3.481

7.  Functional properties of the human copper-transporting ATPase ATP7B (the Wilson's disease protein) and regulation by metallochaperone Atox1.

Authors:  Svetlana Lutsenko; Ruslan Tsivkovskii; Joel M Walker
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

8.  Functional assessment of the carboxy-terminus of the Wilson disease copper-transporting ATPase, ATP7B.

Authors:  Gloria Hsi; Lara M Cullen; D Moira Glerum; Diane W Cox
Journal:  Genomics       Date:  2004-03       Impact factor: 5.736

9.  ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion.

Authors:  Michael A Cater; Sharon La Fontaine; Kristy Shield; Yolanda Deal; Julian F B Mercer
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

10.  The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein.

Authors:  Dominik Huster; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

View more
  28 in total

1.  Communication between the N and C termini is required for copper-stimulated Ser/Thr phosphorylation of Cu(I)-ATPase (ATP7B).

Authors:  Lelita T Braiterman; Arnab Gupta; Raghothama Chaerkady; Robert N Cole; Ann L Hubbard
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

Review 2.  Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance.

Authors:  Svetlana Lutsenko; Arnab Gupta; Jason L Burkhead; Vesna Zuzel
Journal:  Arch Biochem Biophys       Date:  2008-05-21       Impact factor: 4.013

Review 3.  Structural organization of human Cu-transporting ATPases: learning from building blocks.

Authors:  Amanda N Barry; Ujwal Shinde; Svetlana Lutsenko
Journal:  J Biol Inorg Chem       Date:  2009-10-23       Impact factor: 3.358

4.  Middle-aged heterozygous carriers of Wilson's disease do not present with significant phenotypic deviations related to copper metabolism.

Authors:  G Gromadzka; G Chabik; T Mendel; A Wierzchowska; M Rudnicka; A Czlonkowska
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

5.  The architecture of CopA from Archeaoglobus fulgidus studied by cryo-electron microscopy and computational docking.

Authors:  Gregory S Allen; Chen-Chou Wu; Tim Cardozo; David L Stokes
Journal:  Structure       Date:  2011-08-04       Impact factor: 5.006

Review 6.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

Review 7.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

8.  Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.

Authors:  Karoline Leonhardt; Rolf Gebhardt; Joachim Mössner; Svetlana Lutsenko; Dominik Huster
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

9.  An NMR study of the interaction of the N-terminal cytoplasmic tail of the Wilson disease protein with copper(I)-HAH1.

Authors:  Lucia Banci; Ivano Bertini; Francesca Cantini; Chiara Massagni; Manuele Migliardi; Antonio Rosato
Journal:  J Biol Chem       Date:  2009-01-30       Impact factor: 5.157

10.  Localization of the Wilson disease protein in murine intestine.

Authors:  Karl Heinz Weiss; Judith Wurz; Daniel Gotthardt; Uta Merle; Wolfgang Stremmel; Joachim Füllekrug
Journal:  J Anat       Date:  2008-07-25       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.